Development of an enteric-coated formulation containing freeze-dried, viable recombinant Lactococcus lactis for the ileal mucosal delivery of human interleukin-10.
Huyghebaert N, Vermeire A, Neirynck S, Steidler L, Remaut E, Remon JP.
Huyghebaert N, et al. Among authors: steidler l.
Eur J Pharm Biopharm. 2005 Aug;60(3):349-59. doi: 10.1016/j.ejpb.2005.02.012.
Eur J Pharm Biopharm. 2005.
PMID: 15927456
Recombinant hIL-10 producing Lactococcus lactis (Thy12) looks a promising intestinal mucosal delivery system for treatment of Crohn's disease [L. Steidler, W. Hans, L. Schotte, S. Neirynck, F. Obermeirer, W. Falk, W. Fiers, E. Remaut, Treatment of murine coli …
Recombinant hIL-10 producing Lactococcus lactis (Thy12) looks a promising intestinal mucosal delivery system for treatment of Crohn's diseas …